Skip to main content
Top
Published in: Drugs 15/2016

Open Access 01-10-2016 | Review Article

Patient-Centered Interventions to Improve Adherence to Statins: A Narrative Synthesis of Systematically Identified Studies

Authors: Magnus Jörntén-Karlsson, Stéphane Pintat, Michael Molloy-Bland, Staffan Berg, Matti Ahlqvist

Published in: Drugs | Issue 15/2016

Login to get access

Abstract

Poor adherence to statins increases cardiovascular disease risk. We systematically identified 32 controlled studies that assessed patient-centered interventions designed to improve statin adherence. The limited number of studies and variation in study characteristics precluded strict quality criteria or meta-analysis. Cognitive education or behavioural counselling delivered face-to-face multiple times consistently improved statin adherence compared with control groups (7/8 and 3/3 studies, respectively). None of four studies using medication reminders and/or adherence feedback alone reported significantly improved statin adherence. Single interventions that improved statin adherence but were not conducted face-to-face included cognitive education in the form of genetic test results (two studies) and cognitive education via a website (one study). Similar mean adherence measures were reported for 17 intervention arms and were thus compared in a sub-analysis: 8 showed significantly improved statin adherence, but effect sizes were modest (+7 to +22 % points). In three of these studies, statin adherence improved despite already being high in the control group (82–89 vs. 57–69 % in the other studies). These three studies were the only studies in this sub-analysis to include cognitive education delivered face-to-face multiple times (plus other interventions). In summary, the most consistently effective interventions for improving adherence to statins have modest effects and are resource-intensive. Research is needed to determine whether modern communications, particularly mobile health platforms (recently shown to improve medication adherence in other chronic diseases), can replicate or even enhance the successful elements of these interventions while using less time and fewer resources.
Appendix
Available only for authorised users
Literature
3.
go back to reference Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670–81.CrossRefPubMed Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670–81.CrossRefPubMed
4.
go back to reference Mills EJ, Wu P, Chong G, Ghement I, Singh S, Akl EA, et al. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials. QJM. 2011;104(2):109–24.CrossRefPubMed Mills EJ, Wu P, Chong G, Ghement I, Singh S, Akl EA, et al. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials. QJM. 2011;104(2):109–24.CrossRefPubMed
5.
go back to reference Perreault S, Dragomir A, Blais L, Berard A, Lalonde L, White M, et al. Impact of better adherence to statin agents in the primary prevention of coronary artery disease. Eur J Clin Pharmacol. 2009;65(10):1013–24.CrossRefPubMed Perreault S, Dragomir A, Blais L, Berard A, Lalonde L, White M, et al. Impact of better adherence to statin agents in the primary prevention of coronary artery disease. Eur J Clin Pharmacol. 2009;65(10):1013–24.CrossRefPubMed
6.
go back to reference Perreault S, Ellia L, Dragomir A, Cote R, Blais L, Berard A, et al. Effect of statin adherence on cerebrovascular disease in primary prevention. Am J Med. 2009;122(7):647–55.CrossRefPubMed Perreault S, Ellia L, Dragomir A, Cote R, Blais L, Berard A, et al. Effect of statin adherence on cerebrovascular disease in primary prevention. Am J Med. 2009;122(7):647–55.CrossRefPubMed
7.
go back to reference Poluzzi E, Piccinni C, Carta P, Puccini A, Lanzoni M, Motola D, et al. Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study. Eur J Clin Pharmacol. 2011;67(4):407–14.CrossRefPubMed Poluzzi E, Piccinni C, Carta P, Puccini A, Lanzoni M, Motola D, et al. Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study. Eur J Clin Pharmacol. 2011;67(4):407–14.CrossRefPubMed
8.
go back to reference Avorn J, Monette J, Lacour A, Bohn RL, Monane M, Mogun H, et al. Persistence of use of lipid-lowering medications: a cross-national study. JAMA. 1998;279(18):1458–62.CrossRefPubMed Avorn J, Monette J, Lacour A, Bohn RL, Monane M, Mogun H, et al. Persistence of use of lipid-lowering medications: a cross-national study. JAMA. 1998;279(18):1458–62.CrossRefPubMed
9.
go back to reference Helin-Salmivaara A, Lavikainen PT, Korhonen MJ, Halava H, Martikainen JE, Saastamoinen LK, et al. Pattern of statin use among 10 cohorts of new users from 1995 to 2004: a register-based nationwide study. Am J Manag Care. 2010;16(2):116–22.PubMed Helin-Salmivaara A, Lavikainen PT, Korhonen MJ, Halava H, Martikainen JE, Saastamoinen LK, et al. Pattern of statin use among 10 cohorts of new users from 1995 to 2004: a register-based nationwide study. Am J Manag Care. 2010;16(2):116–22.PubMed
10.
go back to reference Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288(4):462–7.CrossRefPubMed Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288(4):462–7.CrossRefPubMed
11.
go back to reference Casula M, Tragni E, Catapano AL. Adherence to lipid-lowering treatment: the patient perspective. Patient Prefer Adherence. 2012;6:805–14.PubMedPubMedCentral Casula M, Tragni E, Catapano AL. Adherence to lipid-lowering treatment: the patient perspective. Patient Prefer Adherence. 2012;6:805–14.PubMedPubMedCentral
12.
go back to reference Fung V, Sinclair F, Wang H, Dailey D, Hsu J, Shaber R. Patients’ perspectives on nonadherence to statin therapy: a focus-group study. Perm J. 2010;14(1):4–10.CrossRefPubMed Fung V, Sinclair F, Wang H, Dailey D, Hsu J, Shaber R. Patients’ perspectives on nonadherence to statin therapy: a focus-group study. Perm J. 2010;14(1):4–10.CrossRefPubMed
13.
go back to reference Harrison TN, Derose SF, Cheetham TC, Chiu V, Vansomphone SS, Green K, et al. Primary nonadherence to statin therapy: patients’ perceptions. Am J Manag Care. 2013;19(4):e133–9.PubMed Harrison TN, Derose SF, Cheetham TC, Chiu V, Vansomphone SS, Green K, et al. Primary nonadherence to statin therapy: patients’ perceptions. Am J Manag Care. 2013;19(4):e133–9.PubMed
14.
go back to reference McGinnis B, Olson KL, Magid D, Bayliss E, Korner EJ, Brand DW, et al. Factors related to adherence to statin therapy. Ann Pharmacother. 2007;41(11):1805–11.CrossRefPubMed McGinnis B, Olson KL, Magid D, Bayliss E, Korner EJ, Brand DW, et al. Factors related to adherence to statin therapy. Ann Pharmacother. 2007;41(11):1805–11.CrossRefPubMed
15.
go back to reference Mann DM, Woodward M, Muntner P, Falzon L, Kronish I. Predictors of nonadherence to statins: a systematic review and meta-analysis. Ann Pharmacother. 2010;44(9):1410–21.CrossRefPubMedPubMedCentral Mann DM, Woodward M, Muntner P, Falzon L, Kronish I. Predictors of nonadherence to statins: a systematic review and meta-analysis. Ann Pharmacother. 2010;44(9):1410–21.CrossRefPubMedPubMedCentral
16.
go back to reference Demonceau J, Ruppar T, Kristanto P, Hughes DA, Fargher E, Kardas P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs. 2013;73(6):545–62.CrossRefPubMedPubMedCentral Demonceau J, Ruppar T, Kristanto P, Hughes DA, Fargher E, Kardas P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs. 2013;73(6):545–62.CrossRefPubMedPubMedCentral
17.
go back to reference Kuntz JL, Safford MM, Singh JA, Phansalkar S, Slight SP, Her QL, et al. Patient-centered interventions to improve medication management and adherence: a qualitative review of research findings. Patient Educ Couns. 2014;97(3):310–26.CrossRefPubMed Kuntz JL, Safford MM, Singh JA, Phansalkar S, Slight SP, Her QL, et al. Patient-centered interventions to improve medication management and adherence: a qualitative review of research findings. Patient Educ Couns. 2014;97(3):310–26.CrossRefPubMed
18.
go back to reference Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;11:CD000011. Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;11:CD000011.
19.
go back to reference Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705.CrossRefPubMedPubMedCentral Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705.CrossRefPubMedPubMedCentral
20.
go back to reference Yilmaz MB, Pinar M, Naharci I, Demirkan B, Baysan O, Yokusoglu M, et al. Being well-informed about statin is associated with continuous adherence and reaching targets. Cardiovasc Drugs Ther. 2005;19(6):437–40.CrossRefPubMed Yilmaz MB, Pinar M, Naharci I, Demirkan B, Baysan O, Yokusoglu M, et al. Being well-informed about statin is associated with continuous adherence and reaching targets. Cardiovasc Drugs Ther. 2005;19(6):437–40.CrossRefPubMed
21.
go back to reference Faulkner MA, Wadibia EC, Lucas BD, Hilleman DE. Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial. Pharmacotherapy. 2000;20(4):410–6.CrossRefPubMed Faulkner MA, Wadibia EC, Lucas BD, Hilleman DE. Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial. Pharmacotherapy. 2000;20(4):410–6.CrossRefPubMed
22.
go back to reference Alsabbagh MW, Lemstra M, Eurich D, Wilson TW, Robertson P, Blackburn DF. Pharmacist intervention in cardiac rehabilitation: a randomized controlled trial. J Cardiopulm Rehabil Prev. 2012;32(6):394–9.CrossRefPubMed Alsabbagh MW, Lemstra M, Eurich D, Wilson TW, Robertson P, Blackburn DF. Pharmacist intervention in cardiac rehabilitation: a randomized controlled trial. J Cardiopulm Rehabil Prev. 2012;32(6):394–9.CrossRefPubMed
23.
go back to reference Charland SL, Agatep BC, Herrera V, Schrader B, Frueh FW, Ryvkin M, et al. Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial. Pharmacogenomics J. 2014;14(3):272–80.CrossRefPubMed Charland SL, Agatep BC, Herrera V, Schrader B, Frueh FW, Ryvkin M, et al. Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial. Pharmacogenomics J. 2014;14(3):272–80.CrossRefPubMed
24.
go back to reference Li JH, Joy SV, Haga SB, Orlando LA, Kraus WE, Ginsburg GS, et al. Genetically guided statin therapy on statin perceptions, adherence, and cholesterol lowering: a pilot implementation study in primary care patients. J Pers Med. 2014;4(2):147–62.CrossRefPubMedPubMedCentral Li JH, Joy SV, Haga SB, Orlando LA, Kraus WE, Ginsburg GS, et al. Genetically guided statin therapy on statin perceptions, adherence, and cholesterol lowering: a pilot implementation study in primary care patients. J Pers Med. 2014;4(2):147–62.CrossRefPubMedPubMedCentral
25.
go back to reference Peng B, Ni J, Anderson CS, Zhu Y, Wang Y, Pu C, et al. Implementation of a structured guideline-based program for the secondary prevention of ischemic stroke in China. Stroke. 2014;45(2):515–9.CrossRefPubMed Peng B, Ni J, Anderson CS, Zhu Y, Wang Y, Pu C, et al. Implementation of a structured guideline-based program for the secondary prevention of ischemic stroke in China. Stroke. 2014;45(2):515–9.CrossRefPubMed
26.
go back to reference Pringle JL, Boyer A, Conklin MH, McCullough JW, Aldridge A. The Pennsylvania Project: pharmacist intervention improved medication adherence and reduced health care costs. Health Aff (Millwood). 2014;33(8):1444–52.CrossRefPubMed Pringle JL, Boyer A, Conklin MH, McCullough JW, Aldridge A. The Pennsylvania Project: pharmacist intervention improved medication adherence and reduced health care costs. Health Aff (Millwood). 2014;33(8):1444–52.CrossRefPubMed
27.
go back to reference Taitel M, Jiang J, Rudkin K, Ewing S, Duncan I. The impact of pharmacist face-to-face counseling to improve medication adherence among patients initiating statin therapy. Patient Prefer Adherence. 2012;6:323–9.CrossRefPubMedPubMedCentral Taitel M, Jiang J, Rudkin K, Ewing S, Duncan I. The impact of pharmacist face-to-face counseling to improve medication adherence among patients initiating statin therapy. Patient Prefer Adherence. 2012;6:323–9.CrossRefPubMedPubMedCentral
28.
go back to reference Thiebaud P, Demand M, Wolf SA, Alipuria LL, Ye Q, Gutierrez PR. Impact of disease management on utilization and adherence with drugs and tests the case of diabetes treatment in the Florida: a Healthy State (FAHS) program. Diabetes Care. 2008;31(9):1717–22.CrossRefPubMedPubMedCentral Thiebaud P, Demand M, Wolf SA, Alipuria LL, Ye Q, Gutierrez PR. Impact of disease management on utilization and adherence with drugs and tests the case of diabetes treatment in the Florida: a Healthy State (FAHS) program. Diabetes Care. 2008;31(9):1717–22.CrossRefPubMedPubMedCentral
29.
go back to reference Johnson SS, Driskell MM, Johnson JL, Dyment SJ, Prochaska JO, Prochaska JM, et al. Transtheoretical model intervention for adherence to lipid-lowering drugs. Dis Manag. 2006;9(2):102–14.CrossRefPubMed Johnson SS, Driskell MM, Johnson JL, Dyment SJ, Prochaska JO, Prochaska JM, et al. Transtheoretical model intervention for adherence to lipid-lowering drugs. Dis Manag. 2006;9(2):102–14.CrossRefPubMed
30.
go back to reference Foreman KF, Stockl KM, Le LB, Fisk E, Shah SM, Lew HC, et al. Impact of a text messaging pilot program on patient medication adherence. Clin Ther. 2012;34(5):1084–91.CrossRefPubMed Foreman KF, Stockl KM, Le LB, Fisk E, Shah SM, Lew HC, et al. Impact of a text messaging pilot program on patient medication adherence. Clin Ther. 2012;34(5):1084–91.CrossRefPubMed
31.
go back to reference Kooy MJ, Van Wijk BLG, Heerdink ER, De Boer A, Bouvy ML. Does the use of an electronic reminder device with or without counseling improve adherence to lipid-lowering treatment? The results of a randomized controlled trial. Front Pharmacol. 2013. doi:10.3389/fphar.2013.00069.PubMedPubMedCentral Kooy MJ, Van Wijk BLG, Heerdink ER, De Boer A, Bouvy ML. Does the use of an electronic reminder device with or without counseling improve adherence to lipid-lowering treatment? The results of a randomized controlled trial. Front Pharmacol. 2013. doi:10.​3389/​fphar.​2013.​00069.PubMedPubMedCentral
32.
go back to reference Pladevall M, Divine G, Wells KE, Resnicow K, Williams LK. A randomized controlled trial to provide adherence information and motivational interviewing to improve diabetes and lipid control. Diabetes Educ. 2015;41(1):136–46.CrossRefPubMed Pladevall M, Divine G, Wells KE, Resnicow K, Williams LK. A randomized controlled trial to provide adherence information and motivational interviewing to improve diabetes and lipid control. Diabetes Educ. 2015;41(1):136–46.CrossRefPubMed
33.
go back to reference Wu JH, Sun CL, Zhang SM, Ren XH, Yang L, Li J, et al. Efects of normalization management on prognosis in elderly patients with coronary artery disease. Chin J Evid Based Med. 2012;12(5):520–3. Wu JH, Sun CL, Zhang SM, Ren XH, Yang L, Li J, et al. Efects of normalization management on prognosis in elderly patients with coronary artery disease. Chin J Evid Based Med. 2012;12(5):520–3.
34.
go back to reference Nieuwkerk PT, Nierman MC, Vissers MN, Locadia M, Greggers-Peusch P, Knape LPM, et al. Intervention to improve adherence to lipid-lowering medication and lipid-levels in patients with an increased cardiovascular risk. Am J Cardiol. 2012;110(5):666–72.CrossRefPubMed Nieuwkerk PT, Nierman MC, Vissers MN, Locadia M, Greggers-Peusch P, Knape LPM, et al. Intervention to improve adherence to lipid-lowering medication and lipid-levels in patients with an increased cardiovascular risk. Am J Cardiol. 2012;110(5):666–72.CrossRefPubMed
35.
go back to reference Kardas P. An education-behavioural intervention improves adherence to statins. Cent Eur J Med. 2013;8(5):580–5. Kardas P. An education-behavioural intervention improves adherence to statins. Cent Eur J Med. 2013;8(5):580–5.
36.
go back to reference Ali F, Laurin MY, Lariviere C, Tremblay D, Cloutier D. The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels. Can J Clin Pharmacol. 2003;10(3):101–6.PubMed Ali F, Laurin MY, Lariviere C, Tremblay D, Cloutier D. The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels. Can J Clin Pharmacol. 2003;10(3):101–6.PubMed
37.
go back to reference Guthrie RM. The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the first myocardial infarction risk reduction program. Clin Ther. 2001;23(6):970–80.CrossRefPubMed Guthrie RM. The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the first myocardial infarction risk reduction program. Clin Ther. 2001;23(6):970–80.CrossRefPubMed
38.
go back to reference Stuurman-Bieze AGG, Hiddink EG, van Boven JFM, Vegter S. Proactive pharmaceutical care interventions improve patients’ adherence to lipid-lowering medication. Ann Pharmacother. 2013;47(11):1448–56.CrossRefPubMed Stuurman-Bieze AGG, Hiddink EG, van Boven JFM, Vegter S. Proactive pharmaceutical care interventions improve patients’ adherence to lipid-lowering medication. Ann Pharmacother. 2013;47(11):1448–56.CrossRefPubMed
39.
go back to reference Brath H, Morak J, Kastenbauer T, Modre-Osprian R, Strohner-Kastenbauer H, Schwarz M, et al. Mobile health (mHealth) based medication adherence measurement—a pilot trial using electronic blisters in diabetes patients. Br J Clin Pharmacol. 2013;76(S1):47–55.CrossRefPubMedPubMedCentral Brath H, Morak J, Kastenbauer T, Modre-Osprian R, Strohner-Kastenbauer H, Schwarz M, et al. Mobile health (mHealth) based medication adherence measurement—a pilot trial using electronic blisters in diabetes patients. Br J Clin Pharmacol. 2013;76(S1):47–55.CrossRefPubMedPubMedCentral
40.
go back to reference Lee SSC, Cheung PYP, Chow MSS. Benefits of individualized counseling by the pharmacist on the treatment outcomes of hyperlipidemia in Hong Kong. J Clin Pharmacol. 2004;44(6):632–9.CrossRefPubMed Lee SSC, Cheung PYP, Chow MSS. Benefits of individualized counseling by the pharmacist on the treatment outcomes of hyperlipidemia in Hong Kong. J Clin Pharmacol. 2004;44(6):632–9.CrossRefPubMed
41.
go back to reference Eussen SRBM, Van Der Elst ME, Klungel OH, Rompelberg CJM, Garssen J, Oosterveld MH, et al. A pharmaceutical care program to improve adherence to statin therapy: a randomized controlled trial. Ann Pharmacother. 2010;44(12):1905–13.CrossRefPubMed Eussen SRBM, Van Der Elst ME, Klungel OH, Rompelberg CJM, Garssen J, Oosterveld MH, et al. A pharmaceutical care program to improve adherence to statin therapy: a randomized controlled trial. Ann Pharmacother. 2010;44(12):1905–13.CrossRefPubMed
42.
go back to reference Vrijens B, Belmans A, Matthys K, de Klerk E, Lesaffre E. Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin. Pharmacoepidemiol Drug Saf. 2006;15(2):115–21.CrossRefPubMed Vrijens B, Belmans A, Matthys K, de Klerk E, Lesaffre E. Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin. Pharmacoepidemiol Drug Saf. 2006;15(2):115–21.CrossRefPubMed
44.
go back to reference Hedegaard U, Kjeldsen LJ, Pottegard A, Bak S, Hallas J. Multifaceted intervention including motivational interviewing to support medication adherence after stroke/transient ischemic attack: a randomized trial. Cerebrovasc Dis Extra. 2014;4(3):221–34.CrossRefPubMedPubMedCentral Hedegaard U, Kjeldsen LJ, Pottegard A, Bak S, Hallas J. Multifaceted intervention including motivational interviewing to support medication adherence after stroke/transient ischemic attack: a randomized trial. Cerebrovasc Dis Extra. 2014;4(3):221–34.CrossRefPubMedPubMedCentral
45.
go back to reference Ma Y, Ockene IS, Rosal MC, Merriam PA, Ockene JK, Gandhi PJ. Randomized trial of a pharmacist-delivered intervention for improving lipid-lowering medication adherence among patients with coronary heart disease. Cholesterol. 2010. doi:10.1155/2010/383281.PubMedPubMedCentral Ma Y, Ockene IS, Rosal MC, Merriam PA, Ockene JK, Gandhi PJ. Randomized trial of a pharmacist-delivered intervention for improving lipid-lowering medication adherence among patients with coronary heart disease. Cholesterol. 2010. doi:10.​1155/​2010/​383281.PubMedPubMedCentral
46.
go back to reference Calvert SB, Kramer JM, Anstrom KJ, Kaltenbach LA, Stafford JA, Allen Lapointe NM. Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial. Am Heart J. 2012;163(4):657–65.CrossRefPubMed Calvert SB, Kramer JM, Anstrom KJ, Kaltenbach LA, Stafford JA, Allen Lapointe NM. Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial. Am Heart J. 2012;163(4):657–65.CrossRefPubMed
47.
go back to reference Stacy JN, Schwartz SM, Ershoff D, Shreve MS. Incorporating tailored interactive patient solutions using interactive voice response technology to improve statin adherence: results of a randomized clinical trial in a managed care setting. Popul Health Manag. 2009;12(5):241–54.CrossRefPubMed Stacy JN, Schwartz SM, Ershoff D, Shreve MS. Incorporating tailored interactive patient solutions using interactive voice response technology to improve statin adherence: results of a randomized clinical trial in a managed care setting. Popul Health Manag. 2009;12(5):241–54.CrossRefPubMed
48.
go back to reference Ho PM, Lambert-Kerzner A, Carey EP, Fahdi IE, Bryson CL, Dee Melnyk S, et al. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial. JAMA Intern Med. 2014;174(2):186–93.CrossRefPubMed Ho PM, Lambert-Kerzner A, Carey EP, Fahdi IE, Bryson CL, Dee Melnyk S, et al. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial. JAMA Intern Med. 2014;174(2):186–93.CrossRefPubMed
49.
go back to reference Goswami NJ, DeKoven M, Kuznik A, Mardekian J, Krukas MR, Liu LZ, et al. Impact of an integrated intervention program on atorvastatin adherence: a randomized controlled trial. Int J Gen Med. 2013;6:647–55.PubMedPubMedCentral Goswami NJ, DeKoven M, Kuznik A, Mardekian J, Krukas MR, Liu LZ, et al. Impact of an integrated intervention program on atorvastatin adherence: a randomized controlled trial. Int J Gen Med. 2013;6:647–55.PubMedPubMedCentral
50.
go back to reference Holdford DA, Inocencio TJ. Adherence and persistence associated with an appointment-based medication synchronization program. J Am Pharm Assoc (2003). 2013;53(6):576–83. Holdford DA, Inocencio TJ. Adherence and persistence associated with an appointment-based medication synchronization program. J Am Pharm Assoc (2003). 2013;53(6):576–83.
51.
go back to reference Evans CD, Eurich DT, Taylor JG, Blackburn DF. The collaborative cardiovascular risk reduction in primary care (CCARP) study. Pharmacotherapy. 2010;30(8):766–75.CrossRefPubMed Evans CD, Eurich DT, Taylor JG, Blackburn DF. The collaborative cardiovascular risk reduction in primary care (CCARP) study. Pharmacotherapy. 2010;30(8):766–75.CrossRefPubMed
53.
Metadata
Title
Patient-Centered Interventions to Improve Adherence to Statins: A Narrative Synthesis of Systematically Identified Studies
Authors
Magnus Jörntén-Karlsson
Stéphane Pintat
Michael Molloy-Bland
Staffan Berg
Matti Ahlqvist
Publication date
01-10-2016
Publisher
Springer International Publishing
Published in
Drugs / Issue 15/2016
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.1007/s40265-016-0640-x

Other articles of this Issue 15/2016

Drugs 15/2016 Go to the issue